Clinitech Laboratory IPO Logo

Clinitech Laboratory IPO

Live Updates, GMP, Subscription Data, and Financial Details

IPO Overview

Listed
Dates Jul 25 to Jul 29 2024
Price Band ₹96
Current GMP ₹115(19.79%)
Subscription 38.96 times

IPO Details

IPO Date
July 25, 2024 to July 29, 2024
Listing Date
Thursday, August 1, 2024
Face Value
₹10 per share
Price
₹96 per share
Lot Size
1200 Shares
Total Issue Size
602,400 shares (aggregating up to ₹5.78 Cr)
Fresh Issue
602,400 shares (aggregating up to ₹5.78 Cr)
Issue Type
Fixed Price Issue IPO
Listing At
BSE SME
Share holding pre issue
1,680,000
Share holding post issue
2,282,400
Market Maker portion
31,200 shares Svcm Securities

IPO Subscription Details

Market Maker
1
Non-Institutional Buyers***
23.28
Retail Investors
49.61
Total **
38.96

Day Wise Sub

DayDay 1 Jul 25, 2024
NII*0.62
Retail4.33
Total2.61
DayDay 2 Jul 26, 2024
NII*1.33
Retail10.10
Total6.03
DayDay 3 Jul 29, 2024
NII*23.28
Retail49.61
Total38.96

Day Wise GMP

Date01-08-2024
Price96.00
GMP65(67.71%)
Estimate List Price161
Date31-07-2024
Price96.00
GMP65(67.71%)
Estimate List Price161
Date30-07-2024
Price96.00
GMP23(23.96%)
Estimate List Price119
Date29-07-2024
Price96.00
GMP0(0.0%)
Estimate List Price96
Date28-07-2024
Price96.00
GMP0(0.0%)
Estimate List Price96
Date27-07-2024
Price96.00
GMP0(0.0%)
Estimate List Price96
Date26-07-2024
Price96.00
GMP0(0.0%)
Estimate List Price96
Date25-07-2024
Price96.00
GMP0(0.0%)
Estimate List Price96
Date24-07-2024
Price96.00
GMP0(0.0%)
Estimate List Price96
Date23-07-2024
Price96.00
GMP0(0.0%)
Estimate List Price96
Date22-07-2024
Price96.00
GMP0(0.0%)
Estimate List Price96
Date21-07-2024
Price96.00
GMP0(0.0%)
Estimate List Price96
Date20-07-2024
Price96.00
GMP0(0.0%)
Estimate List Price96
Date19-07-2024
Price96.00
GMP0(0.0%)
Estimate List Price96
Date18-07-2024
Price96.00
GMP0(0.0%)
Estimate List Price96
Date17-07-2024
Price96.00
GMP0(0.0%)
Estimate List Price96
Date16-07-2024
Price96.00
GMP0(0.0%)
Estimate List Price96

IPO Important Dates

IPO Open Date
Thursday, July 25, 2024
IPO Close Date
Monday, July 29, 2024
Basis of Allotment
Tuesday, July 30, 2024
Initiation of Refunds
Wednesday, July 31, 2024
Credit of Shares to Demat
Wednesday, July 31, 2024
Listing Date
Thursday, August 1, 2024
Cut-off time for UPI mandate confirmation
5 PM on July 29, 2024

IPO Lot Size

ApplicationRetail (Min)
Lots1
Shares1200
Amount₹115,200
ApplicationRetail (Max)
Lots1
Shares1200
Amount₹115,200
ApplicationHNI (Min)
Lots2
Shares2,400
Amount₹230,400

Financial Information

Period EndedPeriod Ended
31 Mar 202431 Mar 2024
31 Mar 202331 Mar 2023
31 Mar 202231 Mar 2022
Period EndedAssets
31 Mar 2024560.79
31 Mar 2023603.33
31 Mar 2022368.74
Period EndedRevenue
31 Mar 2024643.92
31 Mar 2023636.34
31 Mar 2022645.70
Period EndedProfit After Tax
31 Mar 202437.12
31 Mar 202361.31
31 Mar 202251.26
Period EndedNet Worth
31 Mar 2024354.80
31 Mar 2023238.08
31 Mar 2022184.81
Period EndedReserves and Surplus
31 Mar 2024186.80
31 Mar 202388.08
31 Mar 202234.81
Period EndedTotal Borrowing
31 Mar 202486.31
31 Mar 2023102.91
31 Mar 202288.61

Key Performance Indicator

Debt/Equity
0.24
RoNW
10.46%
P/BV
4.55
PAT Margin (%)
5.76
EPS (Rs)
2.21

IPO Reservation

Anchor Investor Shares Offered
-
Market Maker Shares Offered
31,200 (5.18%)
Other Shares Offered
301,200 (50.00%)
Retail Shares Offered
301,200 (50.00%)
Total Shares Offered
602,400 (100%)

Information about company

Founded in 1990, Clinitech Laboratory Limited provides diagnostic and health testing and services. The company performs more than 150 tests in its centres, which are divided into different categories: Biochemical Tests, Immunology Tests, Hematology Tests, Molecular Biology Tests, Serology Tests, Microbiology Tests and Histopathology Tests. Clinitech Laboratory has eight diagnostic centres around Thane and Navi Mumbai. The company conducts more than 3 lakh tests per year in its NABL (National Accreditation Board for Testing and Calibration Laboratories) accredited laboratories equipped with modern technology and high quality equipment. The company's medical testing facilities at Airoli, Navi Mumbai, have been accredited by NABL (National Accreditation Board for Testing and Calibration Laboratories) as per ISO 15189:2012. As of May 31, 2024, the company employed 85 people in various departments.

Objectives of IPO

The Company proposes to utilize the Net Proceeds from the Fresh Issue towards funding the following objects: Expansion of Diagnostic Centres; and General Corporate Purposes.

Disclaimer

All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions. We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application. No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever Please read all Tearms and conditions , and agree to use the App